Kb. Lescale et al., ANTIPLATELET ANTIBODY TESTING IN THROMBOCYTOPENIC PREGNANT-WOMEN, American journal of obstetrics and gynecology, 174(3), 1996, pp. 1014-1018
OBJECTIVE: The purpose of the study was to attempt to distinguish preg
nant women with gestational thrombocytopenia from those with idiopathi
c immune thrombocytopenia by eight different platelet antibody assays.
STUDY DESIGN: Sera from pregnant women with presumed gestational thro
mbocytopenia (n = 160) and idiopathic immune thrombocytopenia (n = 90)
were prospectively tested for indirect and platelet-associated immuno
globulins G and M and complement C3, as well as for serotonin release.
After the results were analyzed, a subset of patients were subsequent
ly analyzed for circulating antiplatelet antibody directed against pla
telet membrane glycoprotein GPIIb/IIIa. RESULTS: Indirect immunoglobul
in G was significantly greater in the 85 women with idiopathic immune
thrombocytopenia than in the 129 women with gestational thrombocytopen
ia (p < 0.001). Platelet-associated immunoglobulin G was elevated in t
he majority of women, both those with gestational thrombocytopenia and
those with idiopathic immune thrombocytopenia. There were also no sta
tistically significant differences in the values for platelet-associat
ed C3 or indirect immunoglobulin M and C3. Levels of platelet-associat
ed immunoglobulin M showed a tendency to be higher in women with gesta
tional thrombocytopenia (p = 0.04), as did the values in the serotonin
release assay (p = 0.06). CONCLUSION: Our data demonstrate that patie
nts with gestational thrombocytopenia had surprisingly high levels of
platelet-associated immunoglobulin despite mild thrombocytopenia. Comp
arison of a relatively large number of patients with idiopathic immune
thrombocytopenia and gestational thrombocytopenia indicates that wome
n with idiopathic immune thrombocytopenia cannot be distinguished from
those with gestational thrombocytopenia by means of one or more of th
e prototypic platelet antiglobulin tests currently in use. Our prelimi
nary data with glycoprotein-specific assays indicate that they may be
more useful.